Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
2015 · Hepatology Research · 81 citations
https://doi.org/10.1111/hepr.12601
K
Kazuya Kitamura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
205
Papers
5.1K
Citations
33
h-index
75
i10-index
Kazuya Kitamura is an academic researcher from Keio University Hospital. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Spine and Intervertebral Disc Pathology & Cervical and Thoracic Myelopathy. The author has an h-index of 33, co-authored 175 publications.
ORCID: 0000-0003-0117-4152Papers by this author
worksAnalysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy
2018 · Hepatology Research · 55 citations
https://doi.org/10.1111/hepr.13196
Enhanced Tumor Localization of Monoclonal Antibody by Treatment with Kininase II Inhibitor and Angiotensin II
1992 · Japanese Journal of Cancer Research · 32 citations
https://doi.org/10.1111/j.1349-7006.1992.tb00093.x
Which frailty scales for patients with adult spinal deformity are feasible and adequate? A systematic review
2022 · The Spine Journal · 31 citations
https://doi.org/10.1016/j.spinee.2022.01.017
Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis
2016 · Cancer Science · 26 citations
https://doi.org/10.1111/cas.12992
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
2023 · Journal of Gastroenterology · 22 citations
https://doi.org/10.1007/s00535-023-01958-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat